Metraipolis › archive › dc_7fac3acb456e

KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations — Europe PMC PMID:42498507

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42498507
DOI
10.1111/ejh.70270
License (as archived)
solo-consultazione
Archived
2026-10-17T20:11:24.008Z
SHA-256 of the archived text
4087d0fda001d126576f72172139e80bacd7160cffa2df1e5b00c291797bb369
Stable URL of this page
https://metraipolis.com/documento/dc_7fac3acb456e

How to cite

KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations — Europe PMC PMID:42498507 — Europe PMC (en), https://europepmc.org/article/MED/42498507 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fac3acb456e (Metraipolis archive dc_7fac3acb456e, sha256 4087d0fda001d126576f72172139e80bacd7160cffa2df1e5b00c291797bb369)
BibTeX
@misc{dc7fac3acb456e,
  title = {KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations — Europe PMC PMID:42498507},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42498507},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fac3acb456e; sha256 4087d0fda001d126576f72172139e80bacd7160cffa2df1e5b00c291797bb369},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42498507. Agents can read the archived copy with the MCP tool read_document.